Nintedanib (150mg) Strip Of 10 Softgel Capsules
NINTEDONE 150 is a potent pharmaceutical product containing Nintedanib (150mg) as its active ingredient. Nintedanib is an oral medication primarily used in the treatment of idiopathic pulmonary fibrosis (IPF) and other chronic diseases involving progressive fibrosis, such as systemic sclerosis-associated interstitial lung disease (SSc-ILD). By inhibiting specific enzymes and growth factors, Nintedanib works to reduce fibrosis and inflammation, slowing the progression of these serious conditions. NINTEDONE 150 is essential in managing such diseases and improving the overall quality of life for patients.
Benefits of NINTEDONE 150:
Effective Treatment for IPF: Nintedanib (150mg) is primarily used to treat idiopathic pulmonary fibrosis (IPF), a progressive and often fatal lung disease characterized by scarring of lung tissue. NINTEDONE 150 helps slow the decline in lung function, reducing the rate at which fibrosis develops.
Reduced Risk of Disease Progression: By targeting multiple pathways involved in fibrosis and inflammation, Nintedanib has been shown to effectively reduce the progression of diseases like IPF and systemic sclerosis-associated interstitial lung disease (SSc-ILD), improving patients’ respiratory function.
Improvement in Respiratory Health: As a tyrosine kinase inhibitor, Nintedanib specifically targets receptors that are involved in the growth of fibroblasts, cells responsible for the formation of scar tissue in the lungs. This helps preserve lung function, improving shortness of breath and other respiratory symptoms.
Management of Chronic Fibrosis: NINTEDONE 150 can help prevent the worsening of fibrotic diseases in patients, reducing hospitalizations and the need for emergency interventions. The medication helps manage chronic conditions more effectively, enabling patients to lead more active and fulfilling lives.
Key Features and Ingredients of NINTEDONE 150:
The key ingredient in NINTEDONE 150 is Nintedanib (150mg), a tyrosine kinase inhibitor that specifically targets fibrosis and inflammation in the lungs. The key features and ingredients of this medication include:
Nintedanib (150mg): The active component of NINTEDONE 150, Nintedanib works by inhibiting various growth factors and enzymes that contribute to the development of fibrosis. It targets vascular endothelial growth factor (VEGF) receptors, fibroblast growth factor (FGF) receptors, and platelet-derived growth factor (PDGF) receptors, all of which are involved in the pathophysiology of fibrotic diseases.
Oral Administration: NINTEDONE 150 is a convenient oral tablet, which is ideal for long-term management. This makes it easier for patients to incorporate the medication into their daily routine.
Combination of Mechanisms: The multi-target approach of Nintedanib is beneficial in treating fibrotic diseases. By inhibiting various pathways involved in tissue damage and scarring, it offers a comprehensive approach to managing diseases like IPF.
Usage and Benefits:
Usage Instructions: The recommended dosage of NINTEDONE 150 is 150mg twice daily, taken with food. Patients are advised to swallow the tablets whole with water, without crushing or breaking them. As with any medication, it\'s crucial to follow the healthcare provider’s specific recommendations and not to exceed the prescribed dose.
Benefits for Fibrotic Diseases:
- Slows Disease Progression: By inhibiting the growth of fibroblasts, Nintedanib reduces the formation of scar tissue in the lungs, helping to slow the progression of conditions like IPF and SSc-ILD.
- Improved Lung Function: NINTEDONE 150 has been shown to help maintain lung function, delaying the onset of more severe symptoms like shortness of breath, fatigue, and persistent cough.
- Prevents Hospitalization: By controlling fibrosis and inflammation, Nintedanib reduces the frequency of acute exacerbations, minimizing the need for hospitalization and emergency treatments.
- Better Quality of Life: For patients suffering from progressive fibrotic diseases, NINTEDONE 150 provides a way to maintain better overall health and quality of life. Patients may experience fewer respiratory symptoms, allowing them to engage in daily activities with greater ease.
Benefits for Preventative Use in High-Risk Populations:
- Prevents Disease Escalation: For patients diagnosed with early-stage IPF or those with a genetic predisposition to fibrosis, NINTEDONE 150 may be used to help prevent the escalation of the disease, preserving lung function and preventing the development of more severe symptoms.
- Support for Long-Term Care: Nintedanib is ideal for long-term treatment, offering patients continuous support in managing chronic conditions like systemic sclerosis-associated interstitial lung disease (SSc-ILD), where disease progression may otherwise be rapid.
Side Effect Management:
- Tolerability: Nintedanib is generally well-tolerated by many patients, although some side effects like diarrhea, nausea, and liver enzyme elevations may occur. These side effects are often manageable with proper care and monitoring.
- Lower Incidence of Serious Complications: Compared to more invasive treatments or experimental therapies, NINTEDONE 150 provides a non-invasive option for managing fibrotic lung diseases with a lower incidence of serious adverse events.
Conclusion:
NINTEDONE 150, containing Nintedanib (150mg), is an essential treatment for individuals suffering from idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases. With its multi-target mechanism, it effectively slows the progression of fibrosis, preserves lung function, and significantly improves the quality of life for patients. Whether used for treating active diseases or preventing further damage in high-risk patients, Nintedanib offers a highly effective, convenient, and well-tolerated option for managing chronic lung conditions. Always consult with a healthcare provider to ensure proper usage and the best treatment plan tailored to individual needs. Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma\'s product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
